In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...

A new weight loss pill developed by the maker of Ozempic and Wegovy helped overweight and obese people lose up to 13% of ...

The highly anticipated new obesity pill shows the potential for greater and faster weight loss than Wegovy. There is a new ...

GLP-1 weight loss medications like Ozempic and Wegovy have become blockbuster ... Semaglutide, the active ingredient in Ozempic, is being developed in pill form by Novo Nordisk and has shown promising ...

A new drug called amycretin is stepping into the spotlight, boasting impressive results that have both researchers and those ...

Novo Nordisk reported that its new obesity pill led to substantial weight loss in an early study, boosting the company’s ...

Share on Pinterest Novo Nordisk’s new weight loss pill, amycretin, has had promising results in an early clinical trial. Image credit: SERGEI GAPON/Getty Images. Amycretin, a new weight loss ...

The pill is made by Novo Nordisk, the same company that makes Ozempic. The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...